Selected research
Market Structure
Global GMP Plasmid Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global GMP Plasmid Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for GMP Plasmid Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for GMP Plasmid Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GMP Plasmid Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for GMP Plasmid Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of GMP Plasmid Service include Aldevron, Andelyn Biosciences, Anemocyte, Catalent Biologics, Creative Biolabs, Esco Aster, VectorBuilder, Eurogentec and Pharmaron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global GMP Plasmid Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of GMP Plasmid Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GMP Plasmid Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the GMP Plasmid Service market size, projected growth trends, production technologies, key applications, and end-use industries.
GMP Plasmid Service Segment by Company
Aldevron
Andelyn Biosciences
Anemocyte
Catalent Biologics
Creative Biolabs
Esco Aster
VectorBuilder
Eurogentec
Pharmaron
PlasmidFactory GmbH
ProBio CDMO
Sartorius
Takara Bio
GMP Plasmid Service Segment by Type
Plasmid for Viral Vector Production
Plasmid for Direct-Acting Therapeutics
Plasmid for In Vitro Transcription Template
Others
GMP Plasmid Service Segment by Application
Gene Therapy and Cell Therapy Industry
mRNA Vaccine and Therapy Industry
Diagnostic and Scientific Research Reagent Industry
Others
GMP Plasmid Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Plasmid Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Plasmid Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Plasmid Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of GMP Plasmid Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GMP Plasmid Service industry.
Chapter 3: Detailed analysis of GMP Plasmid Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GMP Plasmid Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasmid for Viral Vector Production
- Plasmid for Direct-Acting Therapeutics
- Plasmid for In Vitro Transcription Template
- Others
Applications
- Gene Therapy and Cell Therapy Industry
- mRNA Vaccine and Therapy Industry
- Diagnostic and Scientific Research Reagent Industry
- Others
Companies covered
- Aldevron
- Andelyn Biosciences
- Anemocyte
- Catalent Biologics
- Creative Biolabs
- Esco Aster
- VectorBuilder
- Eurogentec
- Pharmaron
- PlasmidFactory GmbH
- ProBio CDMO
- Sartorius
- Takara Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global GMP Plasmid Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Plasmid for Viral Vector Production
- 1.2.3 Plasmid for Direct-Acting Therapeutics
- 1.2.4 Plasmid for In Vitro Transcription Template
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global GMP Plasmid Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Gene Therapy and Cell Therapy Industry
- 1.3.3 mRNA Vaccine and Therapy Industry
- 1.3.4 Diagnostic and Scientific Research Reagent Industry
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global GMP Plasmid Service Growth Trends by Region
- 1.5.1 Global GMP Plasmid Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 GMP Plasmid Service Market Size by Region (2021-2026)
- 1.5.3 GMP Plasmid Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global GMP Plasmid Service Market Dynamics
- 2.1 GMP Plasmid Service Industry Trends
- 2.2 GMP Plasmid Service Industry Drivers
- 2.3 GMP Plasmid Service Industry Opportunities and Challenges
- 2.4 GMP Plasmid Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global GMP Plasmid Service Revenue by Company (2021-2026)
- 3.2 Global GMP Plasmid Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global GMP Plasmid Service Key Company Head office and Area Served
- 3.4 Global GMP Plasmid Service Company, Product Type & Application
- 3.5 Global GMP Plasmid Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global GMP Plasmid Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 GMP Plasmid Service Players Market Share by Revenue in 2025
- 3.6.3 2025 GMP Plasmid Service Tier 1, Tier 2, and Tier 3
4 GMP Plasmid Service Market by Type
- 4.1 Global GMP Plasmid Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global GMP Plasmid Service Market Size by Type (2021-2032)
- 4.3 Global GMP Plasmid Service Market Size Share by Type (2021-2032)
5 GMP Plasmid Service Market by Application
- 5.1 Global GMP Plasmid Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global GMP Plasmid Service Market Size by Application (2021-2032)
- 5.3 Global GMP Plasmid Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Aldevron
- 6.1.1 Aldevron Company Information
- 6.1.2 Aldevron Business Overview
- 6.1.3 Aldevron GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Aldevron GMP Plasmid Service Product Portfolio
- 6.1.5 Aldevron Recent Developments
- 6.2 Andelyn Biosciences
- 6.2.1 Andelyn Biosciences Company Information
- 6.2.2 Andelyn Biosciences Business Overview
- 6.2.3 Andelyn Biosciences GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Andelyn Biosciences GMP Plasmid Service Product Portfolio
- 6.2.5 Andelyn Biosciences Recent Developments
- 6.3 Anemocyte
- 6.3.1 Anemocyte Company Information
- 6.3.2 Anemocyte Business Overview
- 6.3.3 Anemocyte GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Anemocyte GMP Plasmid Service Product Portfolio
- 6.3.5 Anemocyte Recent Developments
- 6.4 Catalent Biologics
- 6.4.1 Catalent Biologics Company Information
- 6.4.2 Catalent Biologics Business Overview
- 6.4.3 Catalent Biologics GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Catalent Biologics GMP Plasmid Service Product Portfolio
- 6.4.5 Catalent Biologics Recent Developments
- 6.5 Creative Biolabs
- 6.5.1 Creative Biolabs Company Information
- 6.5.2 Creative Biolabs Business Overview
- 6.5.3 Creative Biolabs GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Creative Biolabs GMP Plasmid Service Product Portfolio
- 6.5.5 Creative Biolabs Recent Developments
- 6.6 Esco Aster
- 6.6.1 Esco Aster Company Information
- 6.6.2 Esco Aster Business Overview
- 6.6.3 Esco Aster GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Esco Aster GMP Plasmid Service Product Portfolio
- 6.6.5 Esco Aster Recent Developments
- 6.7 VectorBuilder
- 6.7.1 VectorBuilder Company Information
- 6.7.2 VectorBuilder Business Overview
- 6.7.3 VectorBuilder GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 VectorBuilder GMP Plasmid Service Product Portfolio
- 6.7.5 VectorBuilder Recent Developments
- 6.8 Eurogentec
- 6.8.1 Eurogentec Company Information
- 6.8.2 Eurogentec Business Overview
- 6.8.3 Eurogentec GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Eurogentec GMP Plasmid Service Product Portfolio
- 6.8.5 Eurogentec Recent Developments
- 6.9 Pharmaron
- 6.9.1 Pharmaron Company Information
- 6.9.2 Pharmaron Business Overview
- 6.9.3 Pharmaron GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Pharmaron GMP Plasmid Service Product Portfolio
- 6.9.5 Pharmaron Recent Developments
- 6.10 PlasmidFactory GmbH
- 6.10.1 PlasmidFactory GmbH Company Information
- 6.10.2 PlasmidFactory GmbH Business Overview
- 6.10.3 PlasmidFactory GmbH GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 PlasmidFactory GmbH GMP Plasmid Service Product Portfolio
- 6.10.5 PlasmidFactory GmbH Recent Developments
- 6.11 ProBio CDMO
- 6.11.1 ProBio CDMO Company Information
- 6.11.2 ProBio CDMO Business Overview
- 6.11.3 ProBio CDMO GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 ProBio CDMO GMP Plasmid Service Product Portfolio
- 6.11.5 ProBio CDMO Recent Developments
- 6.12 Sartorius
- 6.12.1 Sartorius Company Information
- 6.12.2 Sartorius Business Overview
- 6.12.3 Sartorius GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Sartorius GMP Plasmid Service Product Portfolio
- 6.12.5 Sartorius Recent Developments
- 6.13 Takara Bio
- 6.13.1 Takara Bio Company Information
- 6.13.2 Takara Bio Business Overview
- 6.13.3 Takara Bio GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Takara Bio GMP Plasmid Service Product Portfolio
- 6.13.5 Takara Bio Recent Developments
7 North America
- 7.1 North America GMP Plasmid Service Market Size (2021-2032)
- 7.2 North America GMP Plasmid Service Market Size by Type
- 7.2.1 North America GMP Plasmid Service Market Size by Type (2021-2026)
- 7.2.2 North America GMP Plasmid Service Market Size by Type (2027-2032)
- 7.2.3 North America GMP Plasmid Service Market Share by Type (2021-2032)
- 7.3 North America GMP Plasmid Service Market Size by Application
- 7.3.1 North America GMP Plasmid Service Market Size by Application (2021-2026)
- 7.3.2 North America GMP Plasmid Service Market Size by Application (2027-2032)
- 7.3.3 North America GMP Plasmid Service Market Share by Application (2021-2032)
- 7.4 North America GMP Plasmid Service Market Size by Country
- 7.4.1 North America GMP Plasmid Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America GMP Plasmid Service Market Size by Country (2021-2026)
- 7.4.3 North America GMP Plasmid Service Market Size by Country (2027-2032)
- 7.4.4 North America GMP Plasmid Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe GMP Plasmid Service Market Size (2021-2032)
- 8.2 Europe GMP Plasmid Service Market Size by Type
- 8.2.1 Europe GMP Plasmid Service Market Size by Type (2021-2026)
- 8.2.2 Europe GMP Plasmid Service Market Size by Type (2027-2032)
- 8.2.3 Europe GMP Plasmid Service Market Share by Type (2021-2032)
- 8.3 Europe GMP Plasmid Service Market Size by Application
- 8.3.1 Europe GMP Plasmid Service Market Size by Application (2021-2026)
- 8.3.2 Europe GMP Plasmid Service Market Size by Application (2027-2032)
- 8.3.3 Europe GMP Plasmid Service Market Share by Application (2021-2032)
- 8.4 Europe GMP Plasmid Service Market Size by Country
- 8.4.1 Europe GMP Plasmid Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe GMP Plasmid Service Market Size by Country (2021-2026)
- 8.4.3 Europe GMP Plasmid Service Market Size by Country (2027-2032)
- 8.4.4 Europe GMP Plasmid Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China GMP Plasmid Service Market Size (2021-2032)
- 9.2 China GMP Plasmid Service Market Size by Type
- 9.2.1 China GMP Plasmid Service Market Size by Type (2021-2026)
- 9.2.2 China GMP Plasmid Service Market Size by Type (2027-2032)
- 9.2.3 China GMP Plasmid Service Market Share by Type (2021-2032)
- 9.3 China GMP Plasmid Service Market Size by Application
- 9.3.1 China GMP Plasmid Service Market Size by Application (2021-2026)
- 9.3.2 China GMP Plasmid Service Market Size by Application (2027-2032)
- 9.3.3 China GMP Plasmid Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia GMP Plasmid Service Market Size (2021-2032)
- 10.2 Asia GMP Plasmid Service Market Size by Type
- 10.2.1 Asia GMP Plasmid Service Market Size by Type (2021-2026)
- 10.2.2 Asia GMP Plasmid Service Market Size by Type (2027-2032)
- 10.2.3 Asia GMP Plasmid Service Market Share by Type (2021-2032)
- 10.3 Asia GMP Plasmid Service Market Size by Application
- 10.3.1 Asia GMP Plasmid Service Market Size by Application (2021-2026)
- 10.3.2 Asia GMP Plasmid Service Market Size by Application (2027-2032)
- 10.3.3 Asia GMP Plasmid Service Market Share by Application (2021-2032)
- 10.4 Asia GMP Plasmid Service Market Size by Country
- 10.4.1 Asia GMP Plasmid Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia GMP Plasmid Service Market Size by Country (2021-2026)
- 10.4.3 Asia GMP Plasmid Service Market Size by Country (2027-2032)
- 10.4.4 Asia GMP Plasmid Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa GMP Plasmid Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa GMP Plasmid Service Market Size by Type
- 11.2.1 South America, Middle East & Africa GMP Plasmid Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa GMP Plasmid Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa GMP Plasmid Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa GMP Plasmid Service Market Size by Application
- 11.3.1 South America, Middle East & Africa GMP Plasmid Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa GMP Plasmid Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa GMP Plasmid Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa GMP Plasmid Service Market Size by Country
- 11.4.1 South America, Middle East & Africa GMP Plasmid Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa GMP Plasmid Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa GMP Plasmid Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa GMP Plasmid Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst